Historical record - last NADAC effective date: 11/20/2019
Product Information
FINASTERIDE 5 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0901 per EA under NDC 67877028805. Its NADAC has been published 149 times since Feb 1, 2017.
FDA first approved this application on Jan 5, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877028805
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
11/20/2019
Active Ingredients
FINASTERIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204304FDA Approved
1/5/2017
TE Code
AB
On Market Since
1/5/2017
Pharmacological Classes
Price Statistics
The NADAC for FINASTERIDE 5 MG TABLET has been published 149 times since Feb 1, 2017, and over the history we have for it it has declined 19.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0901 per EA |
|---|---|
| All-time high | $0.1243 (Mar 15, 2017) |
| All-time low | $0.0780 (Aug 21, 2019) |
| Median price | $0.0899 |
| Average price | $0.0910 |
| Largest weekly change | -12.7% (Apr 19, 2017) |
| Weeks tracked | 149 |
| Tracking since | Feb 1, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-19.4%
Last surveyed Dec 4, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Finasteride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
5-alpha Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FINASTERIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FINASTERIDE 5 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.0901 per EA (NDC 67877028805), effective Dec 4, 2019.
How has the price of FINASTERIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for FINASTERIDE 5 MG TABLET has declined 19.4%. It has been tracked across 149 weekly CMS publications since Feb 1, 2017.
What are the highest and lowest recorded NADAC prices for FINASTERIDE 5 MG TABLET?
Since Feb 1, 2017, the NADAC for FINASTERIDE 5 MG TABLET has ranged from a low of $0.0780 (Aug 21, 2019) to a high of $0.1243 (Mar 15, 2017), with a median of $0.0899 per EA.
Are there cheaper alternatives to FINASTERIDE 5 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FINASTERIDE 5 MG TABLET, is $0.0628 per EA — about 30% below FINASTERIDE 5 MG TABLET.
Who manufactures FINASTERIDE 5 MG TABLET?
FINASTERIDE 5 MG TABLET (NDC 67877028805) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.